Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Sarcoma, Secondary cancers, Soft tissue sarcoma
Closed
Phase 2
This trial is looking at changing immune cells to recognize and attack sarcoma cells. The changed immune cells are called afamitresgene autoleucel SPEAR T-cells.
It includes people who have synovial sarcoma. And who can’t have surgery to remove the cancer or it has spread elsewhere in the body.
Recruitment start: 2 August 2019
Recruitment end: 31 July 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sandra Strauss
Adaptimmune
Last reviewed: 12 August 2024
CRUK internal database number: 17621
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
